Polina Kaplan

Dnipropetrovsk City Multifield Coin Hosp 4 City Hematol Ctr

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Weekly Selinexor, Bortezomib, and Dexamethasone (svd) Versus Twice Weekly Bortezomib and Dexamethasone (vd) in Patients with Multiple Myeloma (MM) after One to Three Prior Therapies: Initial Results of the Phase III BOSTON Study

Meletios A. Dimopoulos,Sosana Delimpasi,Maryana Simonova,Ivan Spicka,Ludek Pour,Iryna Kryachok,Maria Gavriatopoulou,Halyna Pylypenko,Holger W. Auner,Xavier Leleu,Vadim Doronin,Polina Kaplan,Roman Hajek,Benjamin Reuben,Tuphan Kanti Dolai,Dinesh Kumar Sinha,Melina Arazy,Paul G. Richardson,Nizar J. Bahlis,Sebastian Grosicki

Journal of Clinical Oncology（2020）

引用29浏览0引用

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Paolo Ghia,Andrzej Pluta,Malgorzata Wach,Daniel Lysak,Tomas Kozak,Martin Simkovic,Polina Kaplan,Iryna Kraychok,Arpad Illes,Javier de la Serna,Sean Dolan,Phillip Campbell,Gerardo Musuraca,Abraham Jacob,Eric Avery,Jae Hoon Lee,Wei Liang,Priti Patel,Cheng Quah,Wojciech Jurczak

JOURNAL OF CLINICAL ONCOLOGYno. 25 (2020): 2849-+

引用260浏览0WOS引用

260

Acalabrutinib Vs Rituximab Plus Idelalisib (idr) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study

Paolo Ghia,Andrzej Pluta,Malgorzata Wach,Daniel Lysak,Tomas Kozak,Martin Simkovic,Polina Kaplan,Iryna Kraychok,Arpad Illes,Javier de la Serna,Sean Dolan,Philip Campbell,Gerardo Musuraca,Abe Jacob,E. J. Avery,Jae Hoon Lee,Wei Liang,Priti Patel,Cheng Quah,Wojciech Jurczak

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia（2019）

引用23浏览0引用

Acalabrutinib Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory CLL: the Randomised, Controlled, Phase 3 ASCEND Trial

Paolo Ghia,Andrzej Pluta,Malgorzata Wach,Daniel Lysak,Tomas Kozak,Martin Simkovic,Polina Kaplan,Iryna Kryachok,Arpad Illes,Javier de la Serna,Sean Dolan,Phillip Campbell,Gerardo Musuraca,Abraham Jacob,Eric Avery,Jae Hoon Lee,Wei Liang,Priti Patel,Cheng Quah,Wojciech Jurczak

Social Science Research Network (2019)

引用0浏览0引用

One year update of a phase 3 randomized study of daratumumab plus bortezomib, melphalan, and prednisone (D VMP) versus bortezomib, melphalan, and prednisone (VMP) in patients …

Meletios A Dimopoulos,Maria-Victoria Mateos,Michele Cavo,Kenshi Suzuki,Andrzej Jakubowiak,Stefan Knop,Chantal Doyen,Paulo Lucio,Zsolt Nagy,Polina Kaplan,Ludek Pour,Mark Cook,Sebastian Grosicki,Andre H Crepaldi,Anna Marina Liberati,Philip Campbell,Tatiana Shelekhova,Sung-Soo Yoon,Genadi Iosava,Tomoaki Fujisaki,Mamta Garg,Christopher Chiu,Jianping Wang,Anupa Kudva,Rachel Kobos,Susan Wroblewski,Ming Qi, Jesus F San-Miguel,Joan Bladé

Bloodno. Supplement 1 (2018): 156-156

引用37浏览0引用

Phase 3 randomized study of daratumumab plus bortezomib, melphalan, and prednisone (D VMP) versus bortezomib, melphalan, and prednisone (VMP) in newly diagnosed multiple …

Maria-Victoria Mateos,Meletios A Dimopoulos,Michele Cavo,Kenshi Suzuki,Andrzej J Jakubowiak,Stefan Knop,Chantal Doyen,Paulo Lucio,Zsolt Nagy,Polina Kaplan,Ludek Pour,Mark Cook,Sebastian Grosicki,Andre H Crepaldi,Anna Marina Liberati,Philip Campbell,Tatiana Shelekhova,Sung-Soo Yoon,Genadi Iosava,Tomoaki Fujisaki,Mamta Garg,Christopher Chiu,Jianping Wang,Robin Carson,Wendy Crist,William Deraedt, Marie Nguyen,Ming Qi, Jesus F San-Miguel

Bloodno. Supplement 1 (2017)

引用19浏览0引用

Daratumumab Plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

María-Victoria Mateos,Meletios A Dimopoulos,Michele Cavo,Kenshi Suzuki,Andrzej Jakubowiak,Stefan Knop,Chantal Doyen,Paulo Lucio,Zsolt Nagy,Polina Kaplan,Ludek Pour,Mark Cook,Sebastian Grosicki,Andre Crepaldi,Anna M Liberati,Philip Campbell,Tatiana Shelekhova,Sung-Soo Yoon,Genadi Iosava,Tomoaki Fujisaki,Mamta Garg,Christopher Chiu,Jianping Wang,Robin Carson,Wendy Crist,William Deraedt,Huong Nguyen,Ming Qi,Jesus San-Miguel

The New England journal of medicine（2017）

引用822浏览0WOS引用

822

Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia

Anders Österborg,Miklós Udvardy,Andrey Zaritskey,Per-Ola Andersson,Sebastian Grosicki,Grzegorz Mazur,Polina Kaplan,Michael Steurer,Anna Schuh,Marco Montillo,Iryna Kryachok,Jan Moritz Middeke,Yaroslav Kulyaba,Grygoriy Rekhtman,Michele Gorczyca,Siobhan Daly,Chai-Ni Chang,Steen Lisby,Ira Gupta

Leukemia & lymphoma（2016）

引用19浏览0WOS引用

Ofatumumab (Ofa) Vs. Physician'S Choice (Pc) Of Therapy In Patients (Pts) With Bulky Fludarabine Refractory (Bfr) Chronic Lymphocytic Leukaemia (Cll): Results Of The Phase Iii Study Omb114242

BLOOD（2014）

引用7浏览0引用

作者统计

#Papers: 9

#Citation: 1216

H-Index: 7

G-Index: 8

Sociability: 5

Diversity: 2

Activity: 1

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn